Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)

ClinicalTrials.gov ID: NCT07115004

Public ClinicalTrials.gov record NCT07115004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 18, 2026, 4:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multicenter, Open-label, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Prophylactic VGA039 in Adolescent and Adult Patients With Von Willebrand Disease (VIVID-6)

Study identification

NCT ID: NCT07115004
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Vega Therapeutics, Inc; Industry
Enrollment: 60 participants

Conditions and interventions

Conditions

Von Willebrand Disease (VWD)

Interventions

VGA039 Drug

Drug

Eligibility (public fields only)

Age range: 12 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 14, 2025
Primary completion: Sep 30, 2028
Completion: Sep 30, 2028
Last update posted: Apr 2, 2026

2025 – 2028

United States locations

U.S. sites: 11
U.S. states: 8
U.S. cities: 10

Facility	City	State	ZIP	Site status
Arkansas Children's Hospital	Little Rock	Arkansas	72202	Recruiting
Luskin Orthopaedic Institute For Children	Los Angeles	California	90007	Recruiting
UC Davis Medical Center	Sacramento	California	95817	Recruiting
University of California San Francisco	San Francisco	California	94143	Recruiting
Emory University Hospital	Atlanta	Georgia	30308	Recruiting
Children's Healthcare of Atlanta	Atlanta	Georgia	30329	Recruiting
University of Minnesota	Minneapolis	Minnesota	55455	Recruiting
Science 37, Inc. (Virtual Clinical MetaSite)	Morrisville	North Carolina	27560	Recruiting
Hemophilia Center of Western PA	Pittsburgh	Pennsylvania	15213	Recruiting
UT Southwestern Children's Hospital	Dallas	Texas	75235	Recruiting
Washington Center for Bleeding Disorders	Seattle	Washington	98101	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07115004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 2, 2026 · Synced May 18, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07115004 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →